£105.19

Springer Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders: 1118 (Advances in Experimental Medicine and Biology, 1118)

Price data last checked 103 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£105 today · usual range £0–£0 · best ever £73

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 628 days • 628 data points (No recent data available)

Historical
Generating forecast...
£107.36 £69.18 £77.51 £85.84 £94.17 £102.50 £110.83 10 June 2024 13 November 2024 19 April 2025 23 September 2025 27 February 2026

Price Distribution

Price distribution over 628 days • 3 price ranges

Days at Price
Current Price
120 days 121 days 387 days · current 0 97 194 290 387 £73-80 £80-87 £100-107 Days at Price

Price Analysis

Most common range: £100-107 (387 days, 61.6%)

Price range: £73 - £107

Price levels: 3 price ranges over 628 days

Description

This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome. From the Back Cover This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome. About the Author Dr Paul C. Guest, Ph.D, is a scientific researcher/writer with 35 years of experience in the fields of metabolic and neurological disorders. This includes experience in both academia and the pharmaceutical industry with the majority of time spent at the University of Cambridge and Merck Sharp & Dohme in the United Kingdom. He has also been affiliated with the University of Campinas in Sao Paulo Brazil since 2015, still focused on advancing the field of biomarkers for neurological disorders such as schizophrenia and Alzheimer’s disease.

Product Specifications

Format
Hardcover
Domain
Amazon UK
Release Date
21 February 2019
Listed Since
07 November 2018

Barcode

No barcode data available

Similar Products You Might Like

Reviews on New Drug Targets in Age-Related Disorders: 1260 (Advances in Experimental Medicine and Biology, 1260)
98% match

Reviews on New Drug Targets in Age-Related Disorders: 1260 (Advances in Experimental Medicine and Biology, 1260)

Springer

£104.33 25 Feb 2026
Identification of Biomarkers, New Treatments, and Vaccines for COVID-19: 1327 (Advances in Experimental Medicine and Biology, 1327)
98% match

Identification of Biomarkers, New Treatments, and Vaccines for COVID-19: 1327 (Advances in Experimental Medicine and Biology, 1327)

Springer

£134.00 28 Jan 2026
Springer Reviews on Biomarker Studies of Metabolic Disorders 1134
98% match

Springer Reviews on Biomarker Studies of Metabolic Disorders 1134

Springer

£108.80 18 Apr 2026
Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
96% match

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Humana

£24.24 24 Feb 2026
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume III: Metabolic and Peripheral Biomarkers: 03
95% match

The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume III: Metabolic and Peripheral Biomarkers: 03

Springer

£88.59 07 Mar 2026
Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment
95% match

Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

Springer

£108.78 15 Apr 2026
Biomarkers for Psychiatric Disorders
95% match

Biomarkers for Psychiatric Disorders

Springer

£106.59 02 Mar 2026
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume IV: Molecular Genetic and Genomic Markers: 04
95% match

The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume IV: Molecular Genetic and Genomic Markers: 04

Springer

£105.90 01 Feb 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
95% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£81.44 05 Apr 2026
Neurophenotypes: Advancing Psychiatry and Neuropsychology in the "OMICS" Era (Innovations in Cognitive Neuroscience)
95% match

Neurophenotypes: Advancing Psychiatry and Neuropsychology in the "OMICS" Era (Innovations in Cognitive Neuroscience)

Springer

£91.83 12 Apr 2026
Springer - Staging Neuropsychiatric Disorders Book
95% match

Springer - Staging Neuropsychiatric Disorders Book

Springer

£107.47 19 Apr 2026
Cerebral Angiogenesis: Methods and Protocols: 1135 (Methods in Molecular Biology, 1135)
95% match

Cerebral Angiogenesis: Methods and Protocols: 1135 (Methods in Molecular Biology, 1135)

Humana

£84.39 27 Feb 2026
Sirtuin Biology in Cancer and Metabolic Disease: Cellular Pathways for Clinical Discovery
95% match

Sirtuin Biology in Cancer and Metabolic Disease: Cellular Pathways for Clinical Discovery

Academic Press

£109.19 17 Feb 2026
GeNeDis 2020: Computational Biology and Bioinformatics: 1338 (Advances in Experimental Medicine and Biology, 1338)
95% match

GeNeDis 2020: Computational Biology and Bioinformatics: 1338 (Advances in Experimental Medicine and Biology, 1338)

Springer

£110.36 15 Apr 2026
The Brain
95% match

The Brain

Routledge

£47.63 07 Mar 2026
Neurobehavioral Manifestations of Neurological Diseases: Diagnosis & Treatment, An Issue of Neurologic Clinics (Volume 34-1) (The Clinics: Radiology, Volume 34-1)
95% match

Neurobehavioral Manifestations of Neurological Diseases: Diagnosis & Treatment, An Issue of Neurologic Clinics (Volume 34-1) (The Clinics: Radiology, Volume 34-1)

Elsevier

£55.11 17 Apr 2026
Oxidative Stress and Dietary Antioxidants in Neurological Diseases
95% match

Oxidative Stress and Dietary Antioxidants in Neurological Diseases

Academic Press

£133.47 09 Mar 2026
Routledge - The Brain - Neurology and Human Behavior Book
95% match

Routledge - The Brain - Neurology and Human Behavior Book

Routledge

£147.25 18 Apr 2026
Human Caspases and Neuronal Apoptosis in Neurodegenerative Diseases
95% match

Human Caspases and Neuronal Apoptosis in Neurodegenerative Diseases

Academic Press

£56.67 09 Apr 2026
Advances in Clinical Chemistry (Volume 39)
95% match

Advances in Clinical Chemistry (Volume 39)

Academic Press

£48.28 19 Apr 2026
Sex Differences in Brain Function and Dysfunction: 62 (Current Topics in Behavioral Neurosciences, 62)
95% match

Sex Differences in Brain Function and Dysfunction: 62 (Current Topics in Behavioral Neurosciences, 62)

£100.00 12 Jan 2026
Lipid Mediators and Their Metabolism in the Brain
95% match

Lipid Mediators and Their Metabolism in the Brain

Springer

£146.40 28 Jan 2026
Springer Proteomic Methods in Neuropsychiatric Research 974
95% match

Springer Proteomic Methods in Neuropsychiatric Research 974

Springer

£116.40 17 Apr 2026